• Vk
  • LinkedIn
  • Youtube
X7 Research
  • News
  • Registration strategy and Сonsulting
    • Budgeting
    • Registration strategy development
    • Study feasibility
    • Vendor selection
    • Data search and analysis
  • Clinical trials
    • Outsourcing CRAs in Russia and the EAEU
    • Development of medical documentation and biostatistics
    • Monitoring
    • Data-management
    • Patient home visits
    • Bioequivalence study
    • Therapeutic equivalence studies
    • Clinical trials of medical devices
  • Registration
    • Audit of the registration dossier
    • Bringing the registration dossier in compliance with the requirements of the EAEU
    • Conversion of registration dossier into XML format
    • PIL readability user testing
    • Translation of the Registration dossier
    • Turnkey registration
  • Post-authorization clinical studies
    • Phase IV studies
    • Non-interventional studies
    • Investigator-initiated studies
    • Post-authorisation safety study
    • Marketing research
  • Pharmacovigilance
    • QPPV in the EAEU
    • Safety monitoring of medical devices
    • Building a pharmacovigilance system
    • Safety in clinical trials
    • Pharmacovigilance audit
    • Pharmacovigilance contact person
  • Therapeutic expertise
    • Clinical trials in Oncology in the EAEU
  • Contact
  • EnglishEnglish
  • Menu

Clinical trial feasibility: the importance of cooperation and steps

11.10.2017/in News /by Evgenii Tkachenko

In clinical trial feasibility involved several groups of specialists. All groups have a common responsibility for conducting clinical trials, which is why it is so important and necessary to be able to cooperate with other teams for the successful management of the request.

There are usually three main teams:

Clinical Operations

Members of this team make valuable inputs into study specific operational aspects based on prior experience including overall startup time, requirement of translated questionnaires, quality and infrastructure. In addition, they can add inputs on overall regulatory requirements including time for approvals, specific requirements such as approvals from other participating countries, contents of the regulatory dossier etc.

Medical Affairs

The Medical Affairs team can take responsibility for answering questions on the prevalence of the disease, presenting symptoms and signs of patients, patient management such as diagnosis, standard care, and overall prognosis. While inputs from investigators are a must, Medical Affairs colleagues can also assess relevance and quality of provided information.

Commercial teams

In various companies, teams specializing in marketing and sales often provide a source information on market size of a particular therapeutic area and class of products, availability of comparator or background therapy. In any case, such information may be verified by Medical /Clinical teams appropriately. Finally, specialists of the business development department can provide information about new sites with which clinical teams may not have any experience.

To conduct a qualitative clinical trial feasibility, a well-designed algorithm should be followed:

Step 1: constitute a team with clear roles and responsibilities and timelines. The task ownership matrix (TOM) can be a general one related to all feasibilities or it may be study specific.

Step 2: select good clinicians or potential investigators for inputs. It would be preferable to seek opinions from physicians you have either worked or interacted with and who have a sound understanding of the disease under study. For protocol feasibilities, it may be advisable to consider 3-4 potential investigators while for site feasibilities, the number of sites would depend on the country, geographical features, disease under study etc. An average of 8-12 specialists. The numbers can vary depending on the therapeutic area, phase of the study, study procedures etc.

Step 3: collect as much of data that is possible but collate it yourself. It may not be advisable to blindly copy all information that you get. It is essential to review and refine the quality of information, without affecting the integrity.

Step 4: adhere to deadlines at any cost. The request for a further increase in time indicates the poor management of the team, as well as the poor performance of the CRO.

Step 5: review, review and review before sending a response to the request. You need to be as accurate, clear and specific as possible in your answers.

X7 Research understands the complexity of clinical trial feasibility, so it is constantly guided by the above algorithm and provides all necessary information on time.

Source: ncbi.

Tags: feasibility
Share this entry
  • Share on Twitter
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail
You might also like
Clinical trial feasibility
Recruitment feasibility

YOU MAY ALSO BE INTERESTED IN

Publications
Readability User Testing of Package Information Leaflets (PIL) in EAEU
Read More
Publications
Remote clinical trial monitoring
Read More
Publications
Post-authorization studies of drug safety in Russia
Read More

RUBRICS

Registration strategy and Сonsulting

Clinical trials

Registration

Post-authorization clinical studies

Pharmacovigilance

LATEST PUBLICATIONS

  • Corrections to clinical trial documents due to COVID-19. Russian experience.
  • WHAT IS BIOEQUIVALENCE
  • THE VOLUME OF RUSSIAN PHARMACEUTICAL MARKET 2016-2019

Tags

bioequivalenceClinical trials in the CISfeasibilitymonitoringRadiopharmaceuticals

CONTACT

2 + 3 = ?

This contact form is deactivated because you refused to accept Google reCaptcha service which is necessary to validate any messages sent by the form.

PRIVACY

Use of this site constitutes your consent to our Privacy Policy.


SOCIAL RESPONSIBILITY

X7 Research’s primary responsibility is to help our clients in bringing medicines & products to the market efficiently and safely.

The Best CRO for Clinical Trials | Full-service Global CRO — X7 Research

The Best CRO in Pharma | Clinical Research Organisation — X7 Research

The Best Contract Research Organisation (CRO) | Trusted CRO — X7 Research

The Best Clinical Research Organisation (CRO): Full Service CRO | X7 Research

The Best CRO in Research | Trusted CRO for Your Trail — X7 Research

The Best Clinical Trial Company | Global Full-service CRO - X7 Research

The Best Pharma CROs: Clinical Trials for Drugs | X7 Research

The Best CROs Company: Clinical Trials with Global CRO — X7 Research

The Best Pre-clinical CRO: Safety Assessment With X7 Research

The Best Clinical Development | Trusted CRO for Your Product: X7 Research

The Best Biostatistical Consulting: Statistical Services | X7 Research

The Best Pharmacovigilance Consulting Services | CRO — X7 Research

Feasibility in Clinical Trials: What is a Feasibility in Clinical Trials?

Clinical Study Trials: What are Clinical Study Trials?

Category
Strategy and consulting
Clinical trials
Registration
Post-authorization clinical studies
Pharmacovigilance

Registration strategy and Сonsulting
Registration strategy development
Budgeting
Study feasibility
Vendor selection
Data search and analysis

Clinical trials
Development of medical documentation and biostatistics
Monitoring
Data management
Patient home visits
Bioequivalence study
Therapeutic equivalence studies

Registration
Audit of the registration dossier
Dossier eaeu
Conversion of registration dossier into xml format
Pil readability user testing
Turnkey registration

Post-authorization clinical studies
Phase iv studies
Non interventional studies
Investigator initiated studies
Post authorisation safety study
Marketing research

Pharmacovigilance
Building a pharmacovigilance system
Safety in clinical trials
Pharmacovigilance audit
Pharmacovigilance contact person

Blog
Contacts

© Copyright 2010-2023 - X7 Research. All rights reserved.
Possible cooperation between regulatory authorities and non-profit medical insurance... The launch of the new global clinical trials database GlobalClinicalTrialsD...
Scroll to top